Charles Schwab

Charles Schwab Portfolio holdings

AUM $578B
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Quarter Return
+10.24%
1 Year Return
+20.71%
3 Year Return
+82.52%
5 Year Return
+159.25%
10 Year Return
+378.54%
AUM
$339B
AUM Growth
+$339B
Cap. Flow
+$7.87B
Cap. Flow %
2.33%
Top 10 Hldgs %
18.14%
Holding
3,646
New
148
Increased
2,578
Reduced
495
Closed
59

Sector Composition

1 Technology 22%
2 Financials 12.68%
3 Healthcare 11.98%
4 Consumer Discretionary 10.85%
5 Industrials 8.85%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EVGO icon
3301
EVgo
EVGO
$515M
$269K ﹤0.01%
27,046
FMS icon
3302
Fresenius Medical Care
FMS
$14.3B
$268K ﹤0.01%
8,246
-626
-7% -$20.3K
AOMR
3303
Angel Oak Mortgage REIT
AOMR
$231M
$267K ﹤0.01%
16,299
CVRX icon
3304
CVRx
CVRX
$201M
$267K ﹤0.01%
21,796
+1,928
+10% +$23.6K
TNGX icon
3305
Tango Therapeutics
TNGX
$755M
$266K ﹤0.01%
24,311
AVTX icon
3306
Avalo Therapeutics
AVTX
$123M
$265K ﹤0.01%
155,779
+23,065
+17% +$39.2K
SLDB icon
3307
Solid Biosciences
SLDB
$435M
$265K ﹤0.01%
150,937
EDR
3308
DELISTED
Endeavor Group Holdings, Inc.
EDR
$264K ﹤0.01%
7,563
+56
+0.7% +$1.96K
CYT
3309
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$259K ﹤0.01%
22,727
+2,158
+10% +$24.6K
XLO icon
3310
Xilio Therapeutics
XLO
$36.8M
$258K ﹤0.01%
+16,100
New +$258K
TDUP icon
3311
ThredUp
TDUP
$1.27B
$257K ﹤0.01%
+20,108
New +$257K
TRVN
3312
DELISTED
Trevena, Inc.
TRVN
$257K ﹤0.01%
440,420
JOAN
3313
DELISTED
JOANN, Inc. Common Stock
JOAN
$257K ﹤0.01%
24,715
+105
+0.4% +$1.09K
RXST icon
3314
RxSight
RXST
$355M
$255K ﹤0.01%
22,635
+2,457
+12% +$27.7K
SNSE icon
3315
Sensei Biotherapeutics
SNSE
$10M
$255K ﹤0.01%
43,865
-2,714
-6% -$15.8K
PYXS icon
3316
Pyxis Oncology
PYXS
$88.1M
$254K ﹤0.01%
+23,094
New +$254K
QSI icon
3317
Quantum-Si Incorporated
QSI
$219M
$252K ﹤0.01%
32,018
WLFC icon
3318
Willis Lease Finance
WLFC
$1.11B
$252K ﹤0.01%
6,674
+866
+15% +$32.7K
INDI icon
3319
indie Semiconductor
INDI
$864M
$251K ﹤0.01%
20,931
VCTR icon
3320
Victory Capital Holdings
VCTR
$4.76B
$251K ﹤0.01%
6,857
CSSE
3321
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$251K ﹤0.01%
18,070
BRDG icon
3322
Bridge Investment Group
BRDG
$249K ﹤0.01%
+9,940
New +$249K
INZY
3323
DELISTED
Inozyme Pharma
INZY
$249K ﹤0.01%
36,427
TGLS icon
3324
Tecnoglass
TGLS
$3.33B
$249K ﹤0.01%
+9,485
New +$249K
ONCT
3325
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$249K ﹤0.01%
109,677